{"id":"https://openalex.org/W1990663756","doi":"https://doi.org/10.1097/yco.0b013e3283413505","title":"Second-generation antipsychotics in major depressive disorder: update and clinical perspective","display_name":"Second-generation antipsychotics in major depressive disorder: update and clinical perspective","alternate_titles":[],"publication_year":2010,"publication_date":"2010-11-17","ids":{"openalex":"https://openalex.org/W1990663756","doi":"https://doi.org/10.1097/yco.0b013e3283413505","mag":"1990663756","pmid":"https://pubmed.ncbi.nlm.nih.gov/21088586"},"language":"en","primary_location":{"id":"doi:10.1097/yco.0b013e3283413505","doi":"https://doi.org/10.1097/yco.0b013e3283413505","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yco.0b013e3283413505","pdf_url":null,"source":{"id":"https://openalex.org/S15258550","display_name":"Current Opinion in Psychiatry","issn_l":"0951-7367","issn":["0951-7367","1473-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990663756"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100450183","display_name":"Jun Chen","orcid":"https://orcid.org/0000-0002-3837-2761","observed_orcids":["https://orcid.org/0000-0002-3837-2761"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2802690428","display_name":"Shanghai Mental Health Center","ror":"https://ror.org/05bd2wa15","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802690428"]},{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"Jun Chen","raw_affiliation_strings":["Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, Shanghai, China","Department of Psychiatry, Mood Disorders Program, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio, USA; Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, Shanghai, China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2802690428"]},{"raw_affiliation_string":"Department of Psychiatry, Mood Disorders Program, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio, USA; Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, Shanghai, China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2802690428","https://openalex.org/I4210108791","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075591850","display_name":"Keming Gao","orcid":"https://orcid.org/0000-0003-1130-2461","observed_orcids":["https://orcid.org/0000-0003-1130-2461"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keming Gao","raw_affiliation_strings":["Department of Psychiatry, Mood Disorders Program, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Mood Disorders Program, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio, USA","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063057736","display_name":"David E. Kemp","orcid":"https://orcid.org/0000-0003-2653-5663","observed_orcids":["https://orcid.org/0000-0003-2653-5663"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David E Kemp","raw_affiliation_strings":["Department of Psychiatry, Mood Disorders Program, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio, USA","to David E. Kemp, MD, 10524 Euclid Avenue, 12th Floor, Cleveland, OH 44106, USA Tel: +1 216 844 2865; fax: +1 216 844 2875; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +1 216 844 2875","to David E. Kemp, MD, 10524 Euclid Avenue, 12th Floor, Cleveland, OH 44106, USA Tel: +1 216 844 2865"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Mood Disorders Program, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio, USA","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"to David E. Kemp, MD, 10524 Euclid Avenue, 12th Floor, Cleveland, OH 44106, USA Tel: +1 216 844 2865; fax: +1 216 844 2875; e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 216 844 2875","institution_ids":[]},{"raw_affiliation_string":"to David E. Kemp, MD, 10524 Euclid Avenue, 12th Floor, Cleveland, OH 44106, USA Tel: +1 216 844 2865","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5063057736"],"corresponding_institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"],"apc_list":null,"apc_paid":null,"fwci":1.2371,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":{"value":0.73603083,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"24","issue":"1","first_page":"10","last_page":"17"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9940000176429749},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.7390000224113464},{"id":"https://openalex.org/keywords/antidepressant-augmentation","display_name":"antidepressant augmentation","score":0.7670000195503235},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.828000009059906},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9819999933242798},{"id":"https://openalex.org/keywords/amisulpride","display_name":"amisulpride","score":0.9549999833106995},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9950000047683716},{"id":"https://openalex.org/keywords/olanzapine-fluoxetine-combination","display_name":"olanzapine-fluoxetine combination","score":0.9179999828338623},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.8370000123977661},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9020000100135803},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antidepressant-efficacy-and-safety","display_name":"antidepressant efficacy and safety","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.858025074005127},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.84307861328125},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.7546126246452332},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.6571300625801086},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.6124292016029358},{"id":"https://openalex.org/C2778999636","wikidata":"https://www.wikidata.org/wiki/Q418785","display_name":"Amisulpride","level":4,"score":0.5907937288284302},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5829342007637024},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.5035228133201599},{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.47391045093536377},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.47019538283348083},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4457215666770935},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.441054105758667},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.4270247220993042},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4164186120033264},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.32980161905288696},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.29294639825820923},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.24616968631744385},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077582","descriptor_name":"Amisulpride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/yco.0b013e3283413505","doi":"https://doi.org/10.1097/yco.0b013e3283413505","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yco.0b013e3283413505","pdf_url":null,"source":{"id":"https://openalex.org/S15258550","display_name":"Current Opinion in Psychiatry","issn_l":"0951-7367","issn":["0951-7367","1473-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Psychiatry","raw_type":"journal-article"},{"id":"pmid:21088586","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21088586","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W101432652","https://openalex.org/W1762787217","https://openalex.org/W1944222706","https://openalex.org/W1967994438","https://openalex.org/W1979187810","https://openalex.org/W1985193354","https://openalex.org/W1991887171","https://openalex.org/W1995984734","https://openalex.org/W2007880575","https://openalex.org/W2009023515","https://openalex.org/W2012655610","https://openalex.org/W2020739757","https://openalex.org/W2021696580","https://openalex.org/W2024174163","https://openalex.org/W2029846038","https://openalex.org/W2034750014","https://openalex.org/W2037486662","https://openalex.org/W2042749834","https://openalex.org/W2046293215","https://openalex.org/W2055629924","https://openalex.org/W2058147526","https://openalex.org/W2065791141","https://openalex.org/W2066834831","https://openalex.org/W2068927187","https://openalex.org/W2070007822","https://openalex.org/W2070828096","https://openalex.org/W2078154303","https://openalex.org/W2088154557","https://openalex.org/W2104518967","https://openalex.org/W2113823824","https://openalex.org/W2114613490","https://openalex.org/W2114693958","https://openalex.org/W2125094332","https://openalex.org/W2131823335","https://openalex.org/W2132324173","https://openalex.org/W2137296158","https://openalex.org/W2137332162","https://openalex.org/W2149154629","https://openalex.org/W2165044084","https://openalex.org/W2196041519","https://openalex.org/W2399110179","https://openalex.org/W2419364113"],"related_works":["https://openalex.org/W2025978141","https://openalex.org/W1994258355","https://openalex.org/W1929751478","https://openalex.org/W2005310936","https://openalex.org/W2074874853","https://openalex.org/W2387905741","https://openalex.org/W7028095774","https://openalex.org/W2526466306","https://openalex.org/W2011054360","https://openalex.org/W2015477517"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"The":[3],"aim":[4],"of":[5,16,41,82,91,121,157,174],"this":[6],"systematic":[7],"review":[8],"was":[9,84,94],"to":[10,35,62,73,112],"examine":[11],"the":[12,60,119,144,155,172],"efficacy":[13,139,170],"and":[14,54,101,165,194],"safety":[15],"second-generation":[17],"antipsychotics":[18],"(SGAs)":[19],"in":[20,118,138,171,184],"nonpsychotic":[21],"major":[22],"depressive":[23],"disorder":[24],"(MDD).":[25],"RECENT":[26],"FINDINGS:":[27],"In":[28,68],"MDD,":[29],"SGA":[30,163,198],"monotherapy":[31,164],"or":[32,154],"adjunctive":[33,52,56,128,166],"therapy":[34,57,167],"conventional":[36],"antidepressants":[37],"showed":[38,168],"rapid":[39],"onset":[40],"antidepressant":[42],"efficacy.":[43],"Although":[44],"maintenance":[45],"data":[46,111],"are":[47,109],"limited,":[48],"quetiapine":[49,102],"monotherapy,":[50],"risperidone":[51],"therapy,":[53],"amisulpride":[55],"significantly":[58,131],"delayed":[59],"time":[61],"relapse":[63],"as":[64],"compared":[65,103],"with":[66,76,86,96,104],"placebo.":[67,105],"general,":[69],"extrapyramidal":[70,195],"symptoms":[71,196],"appeared":[72],"be":[74],"low":[75],"SGAs,":[77],"but":[78,136,178],"a":[79],"higher":[80],"incidence":[81],"akathisia":[83],"observed":[85,95],"aripiprazole.":[87],"An":[88],"elevated":[89],"risk":[90],"weight":[92],"gain":[93],"olanzapine-fluoxetine":[97],"combination,":[98],"risperidone,":[99],"aripiprazole,":[100],"At":[106],"present,":[107],"there":[108],"insufficient":[110],"confidently":[113],"distinguish":[114],"between":[115],"different":[116],"SGAs":[117,129],"treatment":[120,159,173],"MDD.":[122],"A":[123],"recent":[124],"meta-analysis":[125],"found":[126],"that":[127],"were":[130,140,148],"more":[132,181],"effective":[133],"than":[134,176],"placebo,":[135,177],"differences":[137],"not":[141],"identified":[142],"among":[143],"studied":[145],"agents,":[146],"nor":[147],"outcomes":[149],"affected":[150],"by":[151],"trial":[152],"duration":[153],"method":[156],"establishing":[158],"resistance.":[160],"SUMMARY:":[161],"Both":[162],"greater":[169],"MDD":[175],"augmentation":[179],"is":[180],"widely":[182],"utilized":[183],"treatment-resistant":[185],"depression.":[186],"Clinicians":[187],"should":[188],"routinely":[189],"monitor":[190],"for":[191],"cardiometabolic":[192],"side-effects":[193],"during":[197],"therapy.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990663756","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":18},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
